Date
Location
We are happy to announce that Cerba Research will attend the World Vaccine Congress 2023 from October 16 – 19 in Barcelona Spain. The World Vaccine Congress is the largest, most established vaccine meeting. From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain. If you are involved in vaccines or new to them because of the pandemic, this is the most important meeting you will be part of. Uniting vaccine experts – sharing groundbreaking knowledge – tackling the pandemic.
Meet the Cerba Research team and discover how we are setting the standards to protect the world against infectious diseases. Our joint strengths, capabilities, and increased laboratory capacity have created a comprehensive service offering for all our customers. Greater breadth of scientific expertise and leadership, best-in-class logistics, and access to over 1,000 labs across five continents. From early-stage pre-clinical work, including animal modeling and in vitro diagnostics, to large-scale phase 2/3 trials and post-marketing studies. Our combined expertise in assay development and biomarker strategies will accelerate therapy and vaccine development.
Stop by booth 60 and talk to our experts about our experience in
- Preclinical testing services
- Our genomics capabilities to sequence 1000+ whole genomes per week
- A global network spanning the US, Europe, Asia, China and Australia with BSL2 & BSL3 labs
- The largest global PBMC network
- Extended virus biobanking services
- Specialty techniques such as flow cytometry and anatomic pathology services
Download our World Vaccine Congress Resource Pack here
Speaking slot
October 18, 15h30
Translating scientific challenges into preclinical research solutions
There is a high risk of emerging/reemerging pathogens with pandemic potential which poses challenges for the pharma industry to develop appropriate intervention strategies like vaccines, monoclonal antibodies, and antivirals in a timely manner. Teaming with an experienced partner which provides research solutions helps to mitigate some of those challenges and to minimize timelines of the preclinical phase. Animal models, molecular testing methods, and cell-based and functional assays will be discussed.
Speaker: Konrad Stadler, CSO at Viroclinics-DDL
October 19, 10h30
An agile approach to PBMC collection in vaccine trials
Marc van Pruijssen, General Manager Clinical Trial Services & Logistic Excellence and Global Head of Logistics, Sample Handling & CTOS at Viroclinics-DDL, a Cerba Research company, will discuss the challenges and solutions for PBMC collection in the context of clinical trials.
- Critical Aspects of PBMC processing in the context of Clinical Trials
- Challenges of sample handling flows
- Importance of consistent isolation protocols
- Main quality control aspects of PBMC handling
- Upscaling capacity planning for sample collection
- Importance of accessibility to an established global network
Reach out to our experts and discover how we are setting the standards to protect the world against infectious diseases. You can also find out more about our vaccine lab services.